Categories
Uncategorized

Nashville woman explains severe reaction she received after getting Johnson & Johnson vaccine – WSMV Nashville

Sorry, Readability was unable to parse this page for content.

Categories
Uncategorized

Canada waiting on J&J jabs despite US pause, first AstraZeneca clot found – msnNOW



Justin Trudeau wearing a suit and tie: Prime Minister Justin Trudeau said Canada will still receive its first shipment of Johnson & Johnson vaccines but is following developments in the United States over blod clot fears


© Lars Hagberg
Prime Minister Justin Trudeau said Canada will still receive its first shipment of Johnson & Johnson vaccines but is following developments in the United States over blod clot fears

Canada continues to expect its first shipment of Johnson & Johnson Covid-19 vaccines at month’s end despite US and EU pauses over blood clot fears, officials said Tuesday, while also announcing a first Canadian clotting case linked to the AstraZeneca jab.

US health authorities earlier recommended pausing the Johnson & Johnson shot while the company said it would delay its European rollout, after six American women aged between 18 and 48 developed a rare type of clot in the brain along with low platelets.

One later died while another is in critical condition.

“We are still on track to receiving our first shipment of the Johnson & Johnson vaccines by the end of this month,” Prime Minister Justin Trudeau told a news conference.

“But obviously we’re following closely developments in the United States,” he said.

Health Canada authorized the Johnson & Johnson vaccine on March 5, alongside three others. It said it is working with the manufacturer, the US Food and Drug Administration and other international regulators to determine the shot’s safety as it awaits orders for up to 38 million doses.

The agency also identified Canada’s first case of blood clotting with low platelets in a Quebec woman who received an AstraZeneca shot made by the Serum Institute of India.

“The person is at home now recovering,” it said in a statement, adding that it continues to urge using the vaccine, saying the benefits of protection against the coronavirus “outweigh the potential risks.”

As of Tuesday, Canada recorded more than 1,076,000 cases of coronavirus and 23,385 deaths. 

According to the Covid-19 Vaccination Tracker website, 20 percent of the Canadian population of 38 million have received at least one dose.

ast-amc/to

Categories
Uncategorized

Nashville woman explains severe reaction she received after getting Johnson & Johnson vaccine – WSMV Nashville

Sorry, Readability was unable to parse this page for content.

Categories
Uncategorized

Canada waiting on J&J jabs despite US pause, first AstraZeneca clot found – msnNOW



Justin Trudeau wearing a suit and tie: Prime Minister Justin Trudeau said Canada will still receive its first shipment of Johnson & Johnson vaccines but is following developments in the United States over blod clot fears


© Lars Hagberg
Prime Minister Justin Trudeau said Canada will still receive its first shipment of Johnson & Johnson vaccines but is following developments in the United States over blod clot fears

Canada continues to expect its first shipment of Johnson & Johnson Covid-19 vaccines at month’s end despite US and EU pauses over blood clot fears, officials said Tuesday, while also announcing a first Canadian clotting case linked to the AstraZeneca jab.

US health authorities earlier recommended pausing the Johnson & Johnson shot while the company said it would delay its European rollout, after six American women aged between 18 and 48 developed a rare type of clot in the brain along with low platelets.

One later died while another is in critical condition.

“We are still on track to receiving our first shipment of the Johnson & Johnson vaccines by the end of this month,” Prime Minister Justin Trudeau told a news conference.

“But obviously we’re following closely developments in the United States,” he said.

Health Canada authorized the Johnson & Johnson vaccine on March 5, alongside three others. It said it is working with the manufacturer, the US Food and Drug Administration and other international regulators to determine the shot’s safety as it awaits orders for up to 38 million doses.

The agency also identified Canada’s first case of blood clotting with low platelets in a Quebec woman who received an AstraZeneca shot made by the Serum Institute of India.

“The person is at home now recovering,” it said in a statement, adding that it continues to urge using the vaccine, saying the benefits of protection against the coronavirus “outweigh the potential risks.”

As of Tuesday, Canada recorded more than 1,076,000 cases of coronavirus and 23,385 deaths. 

According to the Covid-19 Vaccination Tracker website, 20 percent of the Canadian population of 38 million have received at least one dose.

ast-amc/to

Categories
Uncategorized

Nashville woman explains severe reaction she received after getting Johnson & Johnson vaccine – WSMV Nashville

Sorry, Readability was unable to parse this page for content.

Categories
Uncategorized

Canada waiting on J&J jabs despite US pause, first AstraZeneca clot found – msnNOW



Justin Trudeau wearing a suit and tie: Prime Minister Justin Trudeau said Canada will still receive its first shipment of Johnson & Johnson vaccines but is following developments in the United States over blod clot fears


© Lars Hagberg
Prime Minister Justin Trudeau said Canada will still receive its first shipment of Johnson & Johnson vaccines but is following developments in the United States over blod clot fears

Canada continues to expect its first shipment of Johnson & Johnson Covid-19 vaccines at month’s end despite US and EU pauses over blood clot fears, officials said Tuesday, while also announcing a first Canadian clotting case linked to the AstraZeneca jab.

US health authorities earlier recommended pausing the Johnson & Johnson shot while the company said it would delay its European rollout, after six American women aged between 18 and 48 developed a rare type of clot in the brain along with low platelets.

One later died while another is in critical condition.

“We are still on track to receiving our first shipment of the Johnson & Johnson vaccines by the end of this month,” Prime Minister Justin Trudeau told a news conference.

“But obviously we’re following closely developments in the United States,” he said.

Health Canada authorized the Johnson & Johnson vaccine on March 5, alongside three others. It said it is working with the manufacturer, the US Food and Drug Administration and other international regulators to determine the shot’s safety as it awaits orders for up to 38 million doses.

The agency also identified Canada’s first case of blood clotting with low platelets in a Quebec woman who received an AstraZeneca shot made by the Serum Institute of India.

“The person is at home now recovering,” it said in a statement, adding that it continues to urge using the vaccine, saying the benefits of protection against the coronavirus “outweigh the potential risks.”

As of Tuesday, Canada recorded more than 1,076,000 cases of coronavirus and 23,385 deaths. 

According to the Covid-19 Vaccination Tracker website, 20 percent of the Canadian population of 38 million have received at least one dose.

ast-amc/to

Categories
Uncategorized

Nashville woman explains severe reaction she received after getting Johnson & Johnson vaccine – WSMV Nashville

Sorry, Readability was unable to parse this page for content.

Categories
Uncategorized

358 more COVID-19 cases, 2 deaths, 30K vaccinations reported Tuesday in Utah – KSL.com

Sorry, Readability was unable to parse this page for content.

Categories
Uncategorized

Canada waiting on J&J jabs despite US pause, first AstraZeneca clot found – msnNOW



Justin Trudeau wearing a suit and tie: Prime Minister Justin Trudeau said Canada will still receive its first shipment of Johnson & Johnson vaccines but is following developments in the United States over blod clot fears


© Lars Hagberg
Prime Minister Justin Trudeau said Canada will still receive its first shipment of Johnson & Johnson vaccines but is following developments in the United States over blod clot fears

Canada continues to expect its first shipment of Johnson & Johnson Covid-19 vaccines at month’s end despite US and EU pauses over blood clot fears, officials said Tuesday, while also announcing a first Canadian clotting case linked to the AstraZeneca jab.

US health authorities earlier recommended pausing the Johnson & Johnson shot while the company said it would delay its European rollout, after six American women aged between 18 and 48 developed a rare type of clot in the brain along with low platelets.

One later died while another is in critical condition.

“We are still on track to receiving our first shipment of the Johnson & Johnson vaccines by the end of this month,” Prime Minister Justin Trudeau told a news conference.

“But obviously we’re following closely developments in the United States,” he said.

Health Canada authorized the Johnson & Johnson vaccine on March 5, alongside three others. It said it is working with the manufacturer, the US Food and Drug Administration and other international regulators to determine the shot’s safety as it awaits orders for up to 38 million doses.

The agency also identified Canada’s first case of blood clotting with low platelets in a Quebec woman who received an AstraZeneca shot made by the Serum Institute of India.

“The person is at home now recovering,” it said in a statement, adding that it continues to urge using the vaccine, saying the benefits of protection against the coronavirus “outweigh the potential risks.”

As of Tuesday, Canada recorded more than 1,076,000 cases of coronavirus and 23,385 deaths. 

According to the Covid-19 Vaccination Tracker website, 20 percent of the Canadian population of 38 million have received at least one dose.

ast-amc/to

Categories
Uncategorized

Zoom Burnout Is Real — but It’s Worse for Women. – The New York Times

As companies consider post-pandemic work culture, the solutions to Zoom fatigue aren’t going to be as simple as switching off self-view (which the researchers recommend you do anyway) or abandoning video calls altogether, said Mollie West Duffy, co-author of “No Hard Feelings: The Secret Power of Embracing Emotions at Work,” who has been consulting with companies about plans to return to the office.

“I don’t think anyone has a playbook for how to do this perfectly, so we’re going to all try to do our best and then we’re going to have to be willing to have conversations two months in about how to adapt,” Ms. Duffy said.

For now, she said, leaders and managers should formalize the unspoken rules that have developed over the past year. “Some groups that we’ve been talking to have said, ‘Let’s all turn our videos on for the first five minutes of a call, connect as humans, and then turn it off,’” Ms. Duffy said. “Or telling your team which meetings should have video on and which meetings can have video off.”

“The default has just become video on, and it doesn’t need to be that eight hours a day.”

Certain meetings, like all-company town halls, may end up being video meetings by default because it is worse to have a few people calling in while everyone else is together in a conference room. “You don’t want people feeling left out and feeling like they can’t be heard,” she said.

In May last year, after listening to employees, Arvind Krishna, chief executive of IBM, posted a Work From Home Pledge on his LinkedIn profile. He noted, several times, that switching off video was “100% ok,” and also pledged to keep video calls shorter than the normal duration of 30 or 60 minutes, making them 20 minutes or 45 minutes instead.

“Video fatigue is real,” he said.